HomeTagsDirect Biologics

Direct Biologics

Biotechnology

Direct Biologics Announces FDA Authorization to Expand Ongoing Phase 3 Clinical Study of ExoFlo™ to All-Cause Moderate-to-Severe ARDS

Business Wire - April 5, 2023

Direct Biologics, LLC, a late-stage biotechnology company leveraging its regenerative medicine platform using extracellular vesicles (EVs) secreted from bone marrow-derived mesenchymal stem cells to...

Hot Topics

Keysight Unveils HDMI Physical Layer Compliance Test Solution

Peraton and Okta Collaborate with U.S. DoD to Advance myAuth

Vontier’s Driivz Team Up With ENAPI for EV Roaming Connectivity